{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:06:47Z","timestamp":1784030807791,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["216023"],"award-info":[{"award-number":["216023"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejpn.2026.05.003","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:07:18Z","timestamp":1778170038000},"page":"6-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The emerging role of serum neurofilaments in pediatric neurological disorders"],"prefix":"10.1016","volume":"62","author":[{"given":"Anna","family":"Sverakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2180-5321","authenticated-orcid":false,"given":"Kevin","family":"Rost\u00e1sy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2026.05.003_bib1","article-title":"Neurofilament light chain associates with IVH and ROP in extremely preterm infants","volume":"95","author":"Sj\u00f6bom","year":"2024","journal-title":"Pediatr. Res."},{"issue":"5","key":"10.1016\/j.ejpn.2026.05.003_bib2","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000599","article-title":"Blood neurofilament light chain at the doorstep of clinical application","volume":"6","author":"Leppert","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"10.1016\/j.ejpn.2026.05.003_bib3","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1007\/s00415-021-10429-5","article-title":"Early life serum neurofilament dynamics predict neurodevelopmental outcome of preterm infants","volume":"268","author":"Goeral","year":"2021","journal-title":"J. Neurol."},{"issue":"14","key":"10.1016\/j.ejpn.2026.05.003_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411624","article-title":"Neurofilament-light, a promising biomarker: analytical, metrological and clinical challenges","volume":"24","author":"Coppens","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 14","key":"10.1016\/j.ejpn.2026.05.003_bib5","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1242\/jcs.104729","article-title":"Neurofilaments at a glance","volume":"125","author":"Yuan","year":"2012","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.ejpn.2026.05.003_bib6","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"6","key":"10.1016\/j.ejpn.2026.05.003_bib7","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s40120-023-00535-z","article-title":"Neurofilament light chain in adult and pediatric multiple sclerosis: a promising biomarker to better characterize disease activity and personalize MS treatment","volume":"12","author":"Ghezzi","year":"2023","journal-title":"Neurol Ther"},{"issue":"10","key":"10.1016\/j.ejpn.2026.05.003_bib8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejpn.2026.05.003_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ceb.2020.10.011","article-title":"The dazzling rise of neurofilaments: physiological functions and roles as biomarkers","volume":"68","author":"Bomont","year":"2021","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejpn.2026.05.003_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1275155","article-title":"Neurofilaments in health and Charcot-Marie-Tooth disease","volume":"11","author":"Kotaich","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.ejpn.2026.05.003_bib11","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1515\/cclm-2023-1311","article-title":"Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges","volume":"62","author":"Bayoumy","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"issue":"4","key":"10.1016\/j.ejpn.2026.05.003_bib12","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000749","article-title":"Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis","volume":"7","author":"Reinert","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"10.1016\/j.ejpn.2026.05.003_bib13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1515\/cclm-2023-0660","article-title":"Pediatric reference intervals for serum neurofilament light and glial fibrillary acidic protein using the CALIPER cohort","volume":"62","author":"Stukas","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.ejpn.2026.05.003_bib14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.ejpn.2026.05.003_bib15","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/acn3.51234","article-title":"Blood neurofilament light: a critical review of its application to neurologic disease","volume":"7","author":"Barro","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"5","key":"10.1016\/j.ejpn.2026.05.003_bib16","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF","volume":"67","author":"Rosengren","year":"1996","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.ejpn.2026.05.003_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/00365513.2020.1730434","article-title":"Reference interval and preanalytical properties of serum neurofilament light chain in Scandinavian adults","volume":"80","author":"Hviid","year":"2020","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"3","key":"10.1016\/j.ejpn.2026.05.003_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejpn.2026.05.003_bib19","series-title":"Letter of Support: Neurofilament Light in Childhood Neurological Diseases","year":"2022"},{"issue":"4","key":"10.1016\/j.ejpn.2026.05.003_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac174","article-title":"Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5\u201390 years","volume":"4","author":"Simr\u00e9n","year":"2022","journal-title":"Brain Commun"},{"issue":"9","key":"10.1016\/j.ejpn.2026.05.003_bib21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S1474-4422(23)00210-7","article-title":"Serum neurofilament light chain reference database for individual application in paediatric care","volume":"22","author":"Abdelhak","year":"2023","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.ejpn.2026.05.003_bib22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/13524585231161148","article-title":"The contribution of neurofilament light chain to better characterize pediatric multiple sclerosis","volume":"29","author":"Ghezzi","year":"2023","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.ejpn.2026.05.003_bib23","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1007\/s00415-023-11841-9","article-title":"Serum levels of neurofilament light chains in pediatric multiple sclerosis: a systematic review and meta-analysis","volume":"270","author":"Niculae","year":"2023","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2026.05.003_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jamaneurol.2019.3238","article-title":"Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis","volume":"77","author":"Bjornevik","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejpn.2026.05.003_bib25","series-title":"Early Immune Activation in the Preclinical Phases of Immune-Mediated Neurological Diseases, Manuscript Accepted in Lancet Neurology","author":"Vietzen","year":"2026"},{"issue":"10","key":"10.1016\/j.ejpn.2026.05.003_bib26","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ejpn.2026.05.003_bib27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/13524585211032348","article-title":"Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing-remitting MS","volume":"28","author":"Kuhle","year":"2022","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.ejpn.2026.05.003_bib28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/13524585251335466","article-title":"Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis","volume":"31","author":"Yaldizli","year":"2025","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejpn.2026.05.003_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40893-017-0022-6","article-title":"Pediatric versus adult MS: similar or different?","volume":"2","author":"Ghezzi","year":"2017","journal-title":"Mult Scler Demyelinating Disord"},{"issue":"9","key":"10.1016\/j.ejpn.2026.05.003_bib30","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/brain\/awaa199","article-title":"Improved relapse recovery in paediatric compared to adult multiple sclerosis","volume":"143","author":"Chitnis","year":"2020","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.ejpn.2026.05.003_bib31","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1177\/13524585251359066","article-title":"Reduced brain volumes in children with radiologically isolated syndrome","volume":"31","author":"Koukou","year":"2025","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.ejpn.2026.05.003_bib32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ana.24364","article-title":"Extensive acute axonal damage in pediatric multiple sclerosis lesions","volume":"77","author":"Pfeifenbring","year":"2015","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.ejpn.2026.05.003_bib33","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/1352458519829698","article-title":"Childhood multiple sclerosis is associated with reduced brain volumes at first clinical presentation and brain growth failure","volume":"25","author":"Bartels","year":"2019","journal-title":"Mult. Scler."},{"issue":"19","key":"10.1016\/j.ejpn.2026.05.003_bib34","doi-asserted-by":"crossref","first-page":"e1873","DOI":"10.1212\/WNL.0000000000207791","article-title":"Pretreatment neurofilament light chain serum levels, early disease severity, and treatment response in pediatric multiple sclerosis","volume":"101","author":"Huppke","year":"2023","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ejpn.2026.05.003_bib35","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1177\/13524585221081090","article-title":"Serum neurofilament light-chain levels in children with monophasic MOG-associated disease, multiple sclerosis, and other acquired demyelinating syndromes","volume":"28","author":"Wendel","year":"2022","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejpn.2026.05.003_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106410","article-title":"The utility of serum neurofilament light chain in MOGAD: current insights and future directions","volume":"98","author":"Labib","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.ejpn.2026.05.003_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad063","article-title":"Early blood neurofilament light chain and MOG antibody levels associate with different disease courses in children","volume":"5","author":"Horellou","year":"2023","journal-title":"Brain Commun"},{"key":"10.1016\/j.ejpn.2026.05.003_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104704","article-title":"High serum neurofilament levels are observed close to disease activity events in pediatric-onset MS and MOG antibody-associated diseases","volume":"74","author":"Ziaei","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.ejpn.2026.05.003_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide incidence and prevalence of neuromyelitis optica: a systematic review","volume":"96","author":"Papp","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2026.05.003_bib40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fneur.2020.00415","article-title":"Epidemiology of pediatric NMOSD in Germany and Austria","volume":"11","author":"Lechner","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejpn.2026.05.003_bib41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fped.2020.00339","article-title":"Pediatric NMOSD: a review and position statement on approach to work-up and diagnosis","volume":"8","author":"Tenembaum","year":"2020","journal-title":"Front. Pediatr."},{"issue":"6","key":"10.1016\/j.ejpn.2026.05.003_bib42","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s10072-023-06617-y","article-title":"Worldwide prevalence of neuromyelitis optica spectrum disorder and neuromyelitis optica","volume":"44","author":"Bagherieh","year":"2023","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.ejpn.2026.05.003_bib43","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s10072-023-07277-8","article-title":"Neurofilament light chain as a biomarker in neuromyelitis optica spectrum disorder: a comprehensive review and integrated analysis with glial fibrillary acidic protein","volume":"45","author":"Kim","year":"2024","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.ejpn.2026.05.003_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/JND-210735","article-title":"Neurofilament levels in CSF and serum in an adult SMA cohort treated with nusinersen","volume":"9","author":"Rich","year":"2022","journal-title":"J. Neuromuscul. Dis."},{"issue":"13\u201314","key":"10.1016\/j.ejpn.2026.05.003_bib45","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/neu.2024.0581","article-title":"Blood-based biomarkers for improved characterization of traumatic brain injury","volume":"42","author":"Bazarian","year":"2025","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ejpn.2026.05.003_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/srep36791","article-title":"Serum neurofilament light protein predicts clinical outcome in traumatic brain injury","volume":"6","author":"Shahim","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpn.2026.05.003_bib47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pediatrneurol.2022.03.002","article-title":"Biomarkers in moderate to severe pediatric traumatic brain injury","volume":"130","author":"Munoz Pareja","year":"2022","journal-title":"Pediatr. Neurol."},{"issue":"11","key":"10.1016\/j.ejpn.2026.05.003_bib48","article-title":"Diagnosis and management of mild traumatic brain injury in children","volume":"172","author":"Lumba-Brown","year":"2018","journal-title":"JAMA Pediatr."},{"issue":"6","key":"10.1016\/j.ejpn.2026.05.003_bib49","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s40120-025-00830-x","article-title":"Neurofilament light chain levels as diagnostic and prognostic biomarkers in Guillain-Barr\u00e9 Syndrome: an updated systematic review and meta-analysis","volume":"14","author":"Siconolfi","year":"2025","journal-title":"Neurol Ther"},{"key":"10.1016\/j.ejpn.2026.05.003_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.972367","article-title":"Cerebrospinal fluid neurofilament light chain predicts short-term prognosis in pediatric Guillain-Barr\u00e9 syndrome","volume":"13","author":"Jin","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejpn.2026.05.003_bib51","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s13365-020-00889-2","article-title":"Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus","volume":"26","author":"Tyrberg","year":"2020","journal-title":"J. Neurovirol."},{"issue":"18","key":"10.1016\/j.ejpn.2026.05.003_bib52","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.3390\/jcm13185416","article-title":"Neurofilament light chain as biomarker in encephalitis","volume":"13","author":"Wellmann","year":"2024","journal-title":"J. Clin. Med."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379826000474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379826000474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:35:44Z","timestamp":1784028944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379826000474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":52,"alternative-id":["S1090379826000474"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2026.05.003","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging role of serum neurofilaments in pediatric neurological disorders","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2026.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}